Irisin与糖尿病

doi:10.3969/j.issn.1006-9771.2017.07.012

《中国康复理论与实践》 ›› 2017, Vol. 23 ›› Issue (7): 796-798.doi: 10.3969/j.issn.1006-9771.2017.07.012

Irisin与糖尿病

刘江山^{1, 2}, 张庆文¹

1.上海体育学院体育教育训练学院,上海市 200438;
2.江苏科技大学,江苏张家港市 215600。

收稿日期:2017-02-26 出版日期:2017-07-25 发布日期:2017-08-07
通讯作者: 张庆文(1970-),男,汉族,河南舞钢市人,博士,教授,博士研究生导师,主要研究方向：计算生物学和体育教学与训练。E-mail: zqw@sus.edu.cn。
作者简介:刘江山(1984-),男,汉族,山东滕州市人,博士研究生,讲师,主要研究方向：体育教学与训练。

Role of Irisin in Diabetes (review)

LIU Jiang-shan^{1, 2}, ZHANG Qing-wen¹

1. Shanghai University of Sport, Shanghai 200438, China;
2. Jiangsu University of Science and Technology, Zhangjiagang, Jiangsu 215600, China

Received:2017-02-26 Published:2017-07-25 Online:2017-08-07
Contact: Correspondence to ZHANG Qing-wen. E-mail: zqw@sus.edu.cn

摘要/Abstract

摘要： Irisin是一种肌肉因子,在体内广泛分布。Irisin与糖代谢、脂肪代谢,以及胰岛素抵抗关系密切,有可能成为糖尿病运动疗法研究的新热点。

关键词: 鸢尾素, 糖尿病, 肌肉因子, 胰岛素抵抗, 综述

Abstract: Irisin is one of the myokines, that widely expresses in vavious tissues. Irisin may play a role in metabolism of glucide, lipoid, etc., as well as the insulin resistance, that may be focused in the researches of exercise therapy for diabetes.

Key words: irisin, diabetes, myokines, insulin resistance, review

中图分类号:

R587.1

刘江山, 张庆文. Irisin与糖尿病[J]. 《中国康复理论与实践》, 2017, 23(7): 796-798.

LIU Jiang-shan, ZHANG Qing-wen. Role of Irisin in Diabetes (review)[J]. 《Chinese Journal of Rehabilitation Theory and Practice》, 2017, 23(7): 796-798.

参考文献

[1] Pedersen BK. The diseasome of physical inactivity–and the role of myokines in muscle–fat cross talk [J]. J Physiol, 2009, 587(Pt 23): 5559-5568.
[2] IDF Clinical Guidelines Task Force. Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care [J]. Diabet Med, 2006, 23(6): 579-593.
[3] Pedersen BK. Muscle as a secretory organ [J]. Compr Physiol, 2013, 3(3): 1337-1362.
[4] Hecksteden A, Wegmann M, Steffen A, et al. Irisin and exercise training in humans–results from a randomized controlled training trial [J]. BMC Med, 2013, 3(11): 1-8.
[5] Bostrom P, Wu J, Jedrychowski MP, et al. A PGC-1α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis [J]. Nature, 2012, 481(7382): 463-468.
[6] Aydin S, Kuloglu T. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running [J]. Peptides, 2013, 50: 13-18.
[7] Raschke S, Elsen M, Gassenhuber H, et al. Evidence against a beneficial effect of irisin in humans [J]. PLoS One, 2013, 8(9): 1-12.
[8] Hofman T, Elbeh U, Stengel A. Irisin as a muscle-derived hormone stimulating thermogenesis–A critical update [J]. Peptides, 2014, 54: 89-100.
[9] Aydin S, Kuloglu T. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus [J]. Peptides, 2013, 47: 66-70.
[10] Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss andexercise [J]. Metabolism, 2012, 61(12): 1725-1738.
[11] Sanchis-Gomar F, Lippi G, Mayero S, et al. Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes [J]. J Diabetes, 2012, 4(3): 196.
[12] Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes [J]. Diabetes Res Clin Pract, 2013, 100(1): 96-101.
[13] Stengel A, Hofmann T, Goebel-Stengel M, et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index [J]. Peptides, 2013, 39: 125-130.
[14] Castillo-Quan JI. From white to brown fat through the PGC-1 alpha-dependent myokine irisin: implications for diabetes and obesity [J]. Dis Model Mech, 2012, 5(3): 293-295.
[15] Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement inmetabolic studies [J]. J Exp Biol, 2011, 214(2): 242-253.
[16] Gouveia MC, Vella JP, Cafeo FR, et al. Association between irisin and major chronic diseases: a review [J]. Eur Rev Med Pharmacol Sci, 2016, 20(10): 4072-4077.
[17] Erickson HP. Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? [J]. Adipocyte, 2013, 2(4): 289-293.
[18] Staiger H, Bohm A, Scheler M, et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity [J]. PLoS One, 2013, 8(4): 1-11.
[19] Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome [J]. J Clin Endocrinol Metab, 2013, 98(12): 4899-4907.
[20] Villarroya F. Irisin, turning up the heat [J]. Cell Metab, 2012, 15(3): 277-278.
[21] Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus [J]. J Diabetes Complicat, 2013, 27(4): 365-369.
[22] Yuksel MA, Oncul M, Tuten A, et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus [J]. Diabetes Res Clin Pract, 2014, 104(1): 171-175.
[23] Crujeiras AB, Pardo M, Arturo RR, et al. Longitudinal variation of circulating irisin after an energy restriction induced weight loss and following weight regain in obese men and women [J]. Am J Hum Biol, 2014, 26(2): 198-207.
[24] Assyov Y, Gateva A, Tsakova A, et al. Irisin in the glucose continuum [J]. Exp Clin Endocrinol Diabetes, 2016, 124(1): 22-27.
[25] Saleem A, Safdar A, Haikalis M, et al. Exercise-induced amelioration of diet-induced obesity and diabetes is not regulated by irisin [J]. FASEB J, 2015, 29(Suppl 1): 992-994.
[26] Yang Z, Chen X, Chen Y, et al. Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice [J]. Int J Clin Exp Pathol, 2015, 8(6): 6490-6497.
[27] Bluher S, Panagiotou G, Petroff D, et al. Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children [J]. Obesity (Silver Spring), 2014, 22(7): 1701-1708.
[28] Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome [J]. J Endocrinol Invest, 2017, 40(1): 1-8.
[29] Jeremic N, Chaturvedi P, Tyagi SC. Browning of white fat: novel insight into factors, mechanisms, and therapeutics [J]. J Cell Physiol, 2017, 232(1): 61-68.
[30] 马晓梅. 鸢尾素与2型糖尿病相关性研究状况 [J]. 中国临床药理学杂志, 2015, 31(21): 2161-2163.
[31] Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease [J]. Nature, 2008, 454(7203): 463-469.
[32] Aydin S. Three new players in energy regulation: preptin, adropin and irisin [J]. Peptides, 2014, 56(8): 94-110.
[33] Hashemi MS, Ghaedi K, Salamian A, et al. FNDC5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells [J]. Neuroscience, 2013, 231(12): 296-304.
[34] Dun SL, Lyu RM, Chen YH. Irisin-immunoreactivity in neural and non-neural cells of the rodent [J]. Neuroscience, 2013, 240(14): 155-162.
[35] Wrann CD, White JP, Salogiannnis J, et al. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway [J]. Cell Metab, 2013, 18(5): 649-659.
[36] Gamas L, Matafome P, Seiça R. Irisin and myonectin regulation in the insulin resistant muscle: implications to adipose tissue: muscle crosstalk [J]. J Diabetes Res, 2015, 2015: 359159.
[37] Chen JQ, Huang YY, Gusdon AM, et al. Irisin: a new molecular?marker?and target?in metabolic?disorder [J]. Lipids Health Dis, 2015, 14(5): 1-6.

Irisin与糖尿病

Role of Irisin in Diabetes (review)

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	邵伟婷, 雷江华. 反应中断再定向干预孤独症谱系障碍儿童刻板语言的效果：Scoping综述[J]. 《中国康复理论与实践》, 2024, 30(1): 10-20.
[2]	王航宇, 葛可可, 范永红, 都丽露, 邹敏, 封磊. 基于ICD-11和ICF主动式音乐疗法改善认知障碍老年人认知功能的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 36-43.
[3]	闻嘉宁, 金秋艳, 张琦, 李杰, 司琦. 认知参与型身体活动对发展儿童青少年执行功能的效果：基于ICF的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 44-53.
[4]	葛可可, 范永红, 王航宇, 都丽露, 李长江, 邹敏. 失眠老年人正念干预健康效益的系统综述[J]. 《中国康复理论与实践》, 2024, 30(1): 54-60.
[5]	张婧雅, 邹敏, 孙宏伟, 孙昌隆, 朱峻同. 听障儿童青少年焦虑或抑郁情绪心理干预效果的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1004-1011.
[6]	王俊宇, 杨永, 袁逊, 谢婷, 庄洁. 高强度间歇训练对健康儿童青少年执行功能效果的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1012-1020.
[7]	魏晓微, 杨剑, 魏春艳. 特殊教育学校孤独症谱系障碍儿童参与适应性瑜伽活动的心理与行为效益的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1021-1028.
[8]	杨亚茹, 杨剑. 基于WHO-HPS架构学校身体活动相关健康服务及其健康效益：系统综述的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1040-1047.
[9]	史佳伟, 李凌宇, 杨浩杰, 王琴潞, 邹海欧. 预康复对全膝关节置换术后患者的有效性：系统综述的系统综述[J]. 《中国康复理论与实践》, 2023, 29(9): 1057-1064.
[10]	蒋长好, 黄辰, 高晓妍, 戴元富, 赵国明. 神经反馈训练对老年人认知功能效果的系统综述[J]. 《中国康复理论与实践》, 2023, 29(8): 903-909.
[11]	魏晓微, 杨剑, 魏春艳, 贺启令. 学校环境下适应性体育课程促进智力与发展性残疾儿童心理运动发展的系统综述[J]. 《中国康复理论与实践》, 2023, 29(8): 910-918.
[12]	张园, 杨剑. 基于世界卫生组织健康促进学校架构的学校健康服务及效果：Scoping综述[J]. 《中国康复理论与实践》, 2023, 29(7): 791-799.
[13]	王少璞, 陈钢. 基于世界卫生组织健康促进学校架构的心理行为健康服务及其健康效益：系统综述的系统综述[J]. 《中国康复理论与实践》, 2023, 29(7): 800-807.
[14]	蒋长好, 高晓妍. 短时身体活动对儿童认知功能影响的系统综述[J]. 《中国康复理论与实践》, 2023, 29(6): 667-672.
[15]	袁媛, 杨剑. 社区老年人身体活动融合慢性病管理的健康效益：Scoping综述[J]. 《中国康复理论与实践》, 2023, 29(5): 541-550.